Skip to main content

Table 1 Treatment coverage by Group over time

From: Evaluating the impact of biannual school-based and community-wide treatment on urogenital schistosomiasis in Niger

Year (Y) Study group SAC treated SAC total Mean % SAC treateda Total population treated Total population eligible for treatment % total population treated
Y1 A1 16,563 20,267 82    
A2 18,986 18,809 101    
B1 20,382 24,670 83    
B2 25,281 30,373 83    
C1 22,479 17,598 128 43,600 58,648 74
C2 26,373 25,133 105 57,058 83,772 68
Y2 A1 15,053 13,425 112    
A2 13,553 14,309 95    
B1 19,322 17,378 111    
B2 16,345 17,227 95    
C1 23,512 18,123 130 47,031 60,410 78
C2 33,735 25,883 130 66,671 86,287 77
Y3 Treatment 1 A1 23,281 23,021 101    
A2 25,174 23,586 107    
B1 28,406 22,999 124    
B2 33,231 27,781 120    
C1 26,306 19,663 134 51,598 52,434 98
C2 39,311 24,415 161 74,558 65,106 115
Y3 Treatment 2 A1 0 23,021     
A2 28,203 23,586 120    
B1 0 22,999     
B2 25,274 27,781 91    
C1 0 19,663    52,434  
C2 33,003 24,415 135 61,182 65,106 94
Y4 Treatment 1 A1 20,708 25,368 82    
A2 18,178 21,528 85    
B1 27,316 29,813 92    
B2 29,202 33,822 86    
C1 22,664 19,042 120 42,464 50,761 84
C2 33,861 25,866 131 55,831 68,967 81
Y4 Treatment 2 A1 0 25,368     
A2 16,309 21,528 76    
B1 0 29,813     
B2 26,247 33,822 78    
C1 0 19,042    50,761  
C2 29,290 25,866 113 54,539 68,967 79
  1. aArithmetic mean weighted by village SAC population